Cardiology

Antiplatelets do not up recurrence in intracerebral hemorrhage

(HealthDay)—For patients with intracerebral hemorrhage, those who start antiplatelet therapy do not have an increased risk for recurrence, including those with cerebral microbleeds, according to two studies published online ...

Cardiology

One antiplatelet drug after heart valve replacement

Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots.

Cardiology

Most bleeding events in non-CVD patients are GI-related

(HealthDay)—Among a cohort of individuals without cardiovascular disease (CVD) not receiving antiplatelet therapy, most major bleeding events involved gastrointestinal bleeding and 7 percent of bleeding events were fatal, ...

Cardiology

Guideline-directed medical tx adherence low post CABG

(HealthDay)—Compliance with guideline-directed medical therapy (GDMT) is low, and remains higher in percutaneous coronary intervention (PCI) than in coronary artery bypass grafting (CABG), according to a review published ...

Immunology

Platelets suppress T cell immunity against cancer

Blood platelets help disguise cancer from the immune system by suppressing T cells, report scientists at the Medical University of South Carolina (MUSC) in the May 5, 2017 issue of Science Immunology. In extensive preclinical ...

Cardiology

DAPT use variable in patients with A-fib at risk of stroke

(HealthDay)—For patients with atrial fibrillation at moderate to high risk of stroke, dual antiplatelet therapy (DAPT) use is variable among those undergoing percutaneous coronary intervention (PCI), according to a study ...

page 1 from 5